By PR Newswire
January 26, 2026 | 14:22
The robotics company released a statement correcting or providing additional context about its previously reported sales figures for last year.
By PR Newswire
January 26, 2026 | 14:18
The pizza chain marked a symbolic achievement with its Sanya location, reaching a store count that mirrors its Hong Kong stock exchange ticker number.
By PR Newswire
January 26, 2026 | 14:14
The legal professional's newly launched art marketplace attracted over one billion dollars in committed artwork listings during its inaugural month, demonstrating strong initial traction.
By PR Newswire
January 26, 2026 | 11:52
The digital asset manager partnered with China Pacific Insurance's investment arm to create a half-billion-dollar fund focused on converting traditional assets into blockchain-based tokens.
By PR Newswire
January 26, 2026 | 11:44
American regulators introduced pioneering quality standards for mesenchymal stromal cells, establishing manufacturing and testing benchmarks that could accelerate therapeutic development in regenerative medicine.
By PR Newswire
January 26, 2026 | 11:40
The biopharmaceutical company commenced dosing patients in its thirteen-week American clinical study evaluating an oral GLP-1 receptor agonist for diabetes management.
By PR Newswire
January 26, 2026 | 11:33
The innovation company broadened its intellectual property dispute with the battery manufacturer, adding KTC to the legal action concerning alleged patent infringements.
By PR Newswire
January 26, 2026 | 11:30
New artificial intelligence monitoring systems reduced mean time to resolution by up to seventy percent, delivering substantial cost savings ranging from fifteen to thirty-five percent for technology operations.
By PR Newswire
January 26, 2026 | 11:25
The insurance group completed its corporate relocation to Hong Kong, establishing the city as its official domicile and strengthening its position in the Asian market.
By PR Newswire
January 26, 2026 | 11:19
The Singaporean company introduced the nation's first locally developed pharmaceutical-standard eczema treatment drawing on traditional medicine principles, providing steroid-free relief for sensitive skin conditions.